MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059442 A) filed by Noida Institute Of Engineering And on May 10, 2026, for An Adjuvant Enhanced Vaccine Delivery Composition.
Inventors include Dr. Sharad Sharma; and Dr. Chandana Maji.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The invention relates to an adjuvant enhanced vaccine delivery composition comprising an antigenic component, an adjuvant component, a particulate carrier matrix, a stabilizing excipient phase, and an aqueous pharmaceutically acceptable vehicle. The composition spatially associates antigen and adjuvant to promote coordinated immune presentation while preserving antigen integrity during storage and administration. A release modulating structure provides controlled antigen availability, and an administration interface permits injectable or mucosal use. The composition supports improved immunogenicity, dose efficiency, physical stability, and scalable pharmaceutical manufacture.
Disclaimer: Curated by HT Syndication.
